Zopiclone is not licensed in the UK for anxiety. Its UK licence covers one thing only: the short-term treatment of insomnia in adults. So taking zopiclone for anxiety sits outside what the medicine is approved to do, and taking it during the day sits outside how it is meant to be used at all.
Key facts
- What it is: A hypnotic (sleeping tablet) from the cyclopyrrolone family, one of the Z-drugs.
- Licensed use (UK): Short-term treatment of insomnia in adults. Anxiety is not a licensed use.
- Legal status: Class C controlled drug; Schedule 4, Part I.
- Needs a prescription: Yes.
- Last checked: November 2026
Is zopiclone licensed for anxiety in the UK?
No. The UK Summary of Product Characteristics for zopiclone 7.5 mg tablets gives a single indication: “Zopiclone is indicated for the short-term treatment of insomnia in adults.”
Anxiety does not appear in that sentence, and it does not appear anywhere else in the licence. The NHS page on zopiclone agrees, describing it as “a short-term treatment for sleeping problems (insomnia)”.
Prescribers in the UK may legally prescribe outside a licence. That is called off-label prescribing, and it shifts extra responsibility onto the prescriber.
It is not a loophole you can use yourself. NICE guidance on zopiclone and the other Z-drugs tells doctors to prescribe them “for only short periods of time and strictly according to the licence for the drug”.
Does zopiclone help with anxiety?
Zopiclone is a hypnotic. It is designed to bring on sleep, not to treat a mood or anxiety condition.
The licence is unusually blunt about the risk of using it as a stand-in for mental health treatment. The SmPC warns that zopiclone “does not constitute a treatment for depression and may even mask its symptoms”, and that “pre-existing depression may be unmasked during use of zopiclone”.
Stopping can also leave you feeling worse than when you started. The SmPC describes rebound insomnia, where the symptoms that led to treatment return in an enhanced form after the medicine stops. It adds that this “may be accompanied by other reactions including mood changes, anxiety and restlessness”.
A medicine taken to quieten anxiety can therefore produce anxiety on the way back out. Our guide to zopiclone withdrawal covers what that looks like.
The licence also lists psychiatric and paradoxical reactions, including agitation, aggression, hallucinations and delirium. These are reported more often in older people, and the SmPC says treatment should stop if they occur.
What NICE says about sedatives for anxiety
NICE’s guideline on generalised anxiety disorder is direct about the related benzodiazepine group. Recommendation 1.2.26 of NICE CG113 says: “Do not offer a benzodiazepine for the treatment of GAD in primary or secondary care except as a short-term measure during crises.”
For panic disorder, recommendation 1.3.20 goes further, saying benzodiazepines “should not be prescribed for the treatment of individuals with panic disorder”.
Zopiclone is not a benzodiazepine, as our article on whether zopiclone is a benzodiazepine explains. But UK guidance handles the two groups together where dependence is concerned.
NICE NG215 covers opioids, benzodiazepines, gabapentinoids, Z-drugs and antidepressants in one guideline. Its recommendation 1.2.1 asks prescribers to make sure all suitable options, “including non-pharmacological approaches and watchful waiting”, have been discussed and offered before treatment starts or continues.
Can you take zopiclone during the day for anxiety?
No. Daytime dosing contradicts the licence, the NHS advice and the way the medicine is meant to work.
The SmPC is specific: zopiclone “should be taken in a single intake and not be re-administered during the same night”, shortly before going to bed. The NHS puts the same rule plainly: it comes “as tablets you swallow once a day, before you go to bed”, and you should “not take more than 1 dose in the same night”.
Then there is the twelve-hour rule. The NHS says: “Do not drive, ride a bike or use machinery for 12 hours after taking zopiclone.” The licence says the same, warning against hazardous tasks “in particular during the 12 hours following that administration”.
Take a dose at eight in the morning and that twelve-hour window swallows your whole working day, including the hours you need to drive, work or supervise children.
There is a memory risk too. The SmPC notes that anterograde amnesia may occur, especially when sleep is interrupted, and says the risk is reduced by taking a tablet only when you can sleep uninterrupted for seven to eight hours.
A daytime dose is the opposite of that. If anyone suggests a daytime pattern, ask them to explain the reasoning before you take anything.
Anxiety that keeps you awake
Anxiety and poor sleep often arrive together, and it is reasonable to want help with both. The licence’s answer is to look underneath the insomnia rather than only sedate it.
The SmPC asks prescribers to treat the underlying cause of insomnia where one can be found. It adds: “Since insomnia may be a symptom of depression, the patient should be re-evaluated if insomnia persists.”
If sleep itself is the problem you want to tackle, our complete UK guide to zopiclone and the insomnia hub set out what short-term treatment involves. NICE also asks doctors to consider non-medicine treatments first.
What UK care offers for anxiety instead
NICE CG113 sets out a stepped-care model for generalised anxiety disorder. Each step is matched to how much the condition is affecting you.
| Step | Who it is for | What is offered |
|---|---|---|
| 1 | All known and suspected presentations of GAD | Identification and assessment, education about GAD and the treatment options, active monitoring |
| 2 | Diagnosed GAD that has not improved after step 1 | Individual non-facilitated self-help, individual guided self-help, or psychoeducational groups |
| 3 | Inadequate response to step 2, or marked functional impairment | A choice of a high-intensity psychological intervention (CBT or applied relaxation) or drug treatment, based on your preference |
| 4 | Complex, treatment-refractory GAD with very marked impairment | Highly specialist treatment, multi-agency teams, crisis services, day hospitals or inpatient care |
Sleeping tablets appear nowhere in that model. Where medicine is used at step 3, it is a different class entirely, chosen and reviewed by your prescriber.
You do not always need a referral to start. NHS talking therapies treats “anxiety, including social anxiety and panic disorder”, and says that for many problems “you can refer yourself” “to NHS talking therapies without speaking to a GP”.
You need to be registered with a GP and aged 18 or over, or 16 or over in some areas. A pharmacist can also tell you whether a GP appointment is the better next step.
If you are already taking zopiclone
Do not stop suddenly on your own. The NHS warns that stopping abruptly “can cause withdrawal symptoms such as feeling agitated or anxious”, and says your doctor will reduce the dose gradually so you can stop safely.
Take it exactly as your prescriber tells you, and book a review rather than changing anything yourself. The SmPC says treatment “should be as short as possible and should not exceed four weeks including the period of tapering off”, and that going beyond that should not happen without re-evaluating your situation.
NICE NG215 recommends regular reviews for anyone taking a Z-drug, and lists use outside the licensed indication as a reason to review more often. That applies squarely to anyone taking zopiclone for anxiety.
Regulators have been tightening the language here. On 8 January 2026 the MHRA announced stronger dependency and addiction warnings on gabapentinoids, benzodiazepines and Z-drugs, the classes used for neuropathic pain, anxiety and insomnia.
Packs will carry the warning “May cause addiction, dependence, and withdrawal reactions”, and leaflets will give clearer definitions of dependence and addiction. The MHRA’s chief safety officer noted that “addiction and dependency can happen to anyone taking these medicines”.
NICE TA77 also tells prescribers that if one of these hypnotics does not work, they should not simply prescribe another. Our guide to whether zopiclone is addictive covers the dependence picture.
Driving, work and the law
The twelve-hour rule is the practical one. A dose taken for daytime anxiety puts you inside that window exactly when you need to be alert.
The law adds a second layer. GOV.UK drug-driving guidance says it is an offence to drive with more than the specified limits of certain drugs in your blood if you have not been prescribed them, and names diazepam and temazepam among the medicines to discuss with your doctor.
Zopiclone is not on that named list. That is not permission to drive on it, because driving while unfit through drugs is a separate offence regardless of any limit.
On legal status, zopiclone is a Class C controlled drug under Schedule 2 to the Misuse of Drugs Act 1971, and sits in Schedule 4, Part I of the Misuse of Drugs Regulations 2001, where it was added on 10 June 2014. Our explainer on zopiclone as a controlled drug covers what that means for prescriptions and travel.
When to get help
Call 999 or go to A&E now if someone who has taken zopiclone is very hard to wake, is breathing slowly, shallowly or noisily, has blue or grey lips or fingertips, or has collapsed. The risk is higher if alcohol or an opioid has also been taken.
Call 999 if you are having thoughts of harming yourself or ending your life, or for a serious allergic reaction: a swollen throat or tongue, trouble breathing or swallowing, or an itchy raised rash.
Call NHS 111 if your anxiety is getting worse, if you feel agitated, confused or unusually low, if you have taken more than your prescribed dose, or if you have been sleepwalking or doing things while not fully awake. If you are told to go to A&E, do not drive yourself.
Speak to your GP or pharmacist if you are taking zopiclone for anxiety, if you want to stop, if it has stopped working, or if you are worried about dependence. Ask for a review rather than changing the dose yourself.
Report a suspected side effect to the MHRA through the Yellow Card scheme.
Frequently asked questions
Can you take zopiclone during the day for anxiety?
No. Zopiclone is licensed as a single dose shortly before bed, never twice in one night. The NHS says not to drive, cycle or use machinery for 12 hours after a dose.
Does zopiclone help with anxiety?
It is a sleeping tablet, not an anxiety treatment, and anxiety is not part of its UK licence. The product information warns that it does not treat depression and may mask its symptoms, and that stopping can bring mood changes, anxiety and restlessness.
Is it legal to take zopiclone for anxiety in the UK?
Zopiclone is a prescription-only medicine and a Class C controlled drug in Schedule 4, Part I. A prescriber may prescribe outside the licence and takes extra responsibility for doing so.
Can a GP prescribe zopiclone for anxiety?
A GP can prescribe off-label, but would need a clear reason and should review it more often. NICE asks prescribers to discuss and offer non-medicine options before starting or continuing a Z-drug.
What does the NHS offer for anxiety instead?
NICE sets out stepped care: education and active monitoring, then self-help or psychoeducational groups, then a choice of CBT, applied relaxation or drug treatment. You can refer yourself to NHS talking therapies without seeing a GP.
Can zopiclone make anxiety worse?
It can. The product information describes rebound symptoms on stopping, which may come with mood changes, anxiety and restlessness, and lists agitation and aggression among paradoxical reactions. Tell your prescriber if any of these happen.
References
- Zopiclone 7.5 mg film-coated tablets — Summary of Product Characteristics, electronic medicines compendium (Milpharm Limited), text revised 8 April 2026, accessed November 2026.
- Zopiclone: a medicine used to treat insomnia, NHS, page last reviewed 22 June 2026, accessed November 2026.
- Generalised anxiety disorder and panic disorder in adults: management (CG113), recommendations, NICE, accessed November 2026.
- Guidance on the use of zaleplon, zolpidem and zopiclone for the short-term management of insomnia (TA77), NICE, accessed November 2026.
- Medicines associated with dependence or withdrawal symptoms (NG215), recommendations, NICE, accessed November 2026.
- MHRA strengthening dependency and addiction warnings on medicines used to treat pain, anxiety, and insomnia, Medicines and Healthcare products Regulatory Agency, published 8 January 2026, accessed November 2026.
- NHS talking therapies for anxiety and depression, NHS, accessed November 2026.
- Misuse of Drugs Act 1971, Schedule 2 (Class C drugs, Part III), legislation.gov.uk, accessed November 2026.
- Misuse of Drugs Regulations 2001, Schedule 4, Part I, legislation.gov.uk, accessed November 2026.
- Drugs and driving: the law, GOV.UK, accessed November 2026.
- Yellow Card scheme, MHRA, accessed November 2026.
This article is for information only and does not replace advice from your doctor or pharmacist. Read our medical disclaimer.